Andrea Ňaršanská

May CTC technologies promote better cancer management?

Martin Pešta, Vlastimil Kulda, Andrea Ňaršanská et al. · The EPMA Journal · 2015 · 38 citations · Full text

Ctc Assessment, Tumor Biology, May Ctc Technologies +14

Surgery for breast cancer liver metastases - factors determining results.

Vladislav Třeška, Monika Černá, Václav Liška et al. · PubMed · 2014 · 25 citations

CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer

Šárka Svobodová, Radek Kučera, Ondřej Fiala et al. · Anticancer Research · 2018 · 15 citations · Full text

Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study.

Petr Pazdiora, Šárka Svobodová, Radka Fuchsová et al. · PubMed · 2011 · 14 citations

Prognostic importance of some clinical and therapeutic factors for the effect of portal vein embolization in patients with primarily inoperable colorectal liver metastases

Vladislav Třeška, Tomáš Skalický, A Sutnar et al. · Archives of Medical Science · 2013 · 10 citations · Full text